首页 | 本学科首页   官方微博 | 高级检索  
     

退行性视网膜病变中睫状神经营养因子神经保护作用的研究进展
引用本文:Chen R,Li GL. 退行性视网膜病变中睫状神经营养因子神经保护作用的研究进展[J]. 中华眼科杂志, 2011, 47(6): 568-572. DOI: 10.3760/cma.j.issn.0412-4081.2011.06.021
作者姓名:Chen R  Li GL
作者单位:北京同仁眼科中心,北京市眼科学与视觉科学重点实验室,首都医科大学附属北京同仁医院,100730
摘    要:
多项体内外及临床试验结果均证实睫状神经营养因子(CNTF)对光感受器细胞具有良好的神经保护作用,同时也对视网膜多种神经细胞的结构和功能产生不同的影响.CNTF对光感受器细胞保护作用的分子机制涉及Stat、Erk及Akt等信号传导途径,其中Müller细胞发挥着重要作用.细胞包囊技术为CNTF提供了有效的给药途径,在多种退行性视网膜病变的动物模型中均取得良好疗效,其临床应用中的安全性和有效性正在进行评估,这将为CNTF进入临床应用奠定基础.(中华眼科杂志,2011,47:568-572)
Abstract:
Ciliary neurotrophic factor (CNTF) has been showing neuroprotective effects on photoreceptors in a variety of in vivo and in vitro experiments and clinical trials. CNTF causes morphological and functional alterations in various retinal nerve cells. The neuroprotection mechanism of CNTF involves STAT-dependant, ERK-dependant, and Akt-dependant signaling technology (ECT) device is an efficient administration approach to deliver CNTF into the eyes, which is effective in retarding photoreceptor degeneration in several animal models with retinal degenerative diseases. The safety and efficiency of the device in clinical trials are also being evaluated currently for further clinical use in human eyes as a potential treatment.

关 键 词:视网膜病性  神经保护药  睫状神经营养因子

Neuroprotection of retinal degenerative disease by ciliary neurotrophic factor
Chen Rui,Li Gen-lin. Neuroprotection of retinal degenerative disease by ciliary neurotrophic factor[J]. Chinese Journal of Ophthalmology, 2011, 47(6): 568-572. DOI: 10.3760/cma.j.issn.0412-4081.2011.06.021
Authors:Chen Rui  Li Gen-lin
Affiliation:Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Lab, Beijing, China.
Abstract:
Ciliary neurotrophic factor (CNTF) has been showing neuroprotective effects on photoreceptors in a variety of in vivo and in vitro experiments and clinical trials. CNTF causes morphological and functional alterations in various retinal nerve cells. The neuroprotection mechanism of CNTF involves STAT-dependant, ERK-dependant, and Akt-dependant signaling technology (ECT) device is an efficient administration approach to deliver CNTF into the eyes, which is effective in retarding photoreceptor degeneration in several animal models with retinal degenerative diseases. The safety and efficiency of the device in clinical trials are also being evaluated currently for further clinical use in human eyes as a potential treatment.
Keywords:Retinal degeneration  Neuroprotective agents  Ciliary neurotrophic factor
本文献已被 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号